About Dr Emil Toma / Hotel Dieu de Montreal
Clinical Trials at Dr Emil Toma / Hotel Dieu de Montreal
During the past decade, Dr Emil Toma / Hotel Dieu de Montreal conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Dr Emil Toma / Hotel Dieu de Montreal
According to Clinical.Site data, the most researched conditions in "Dr Emil Toma / Hotel Dieu de Montreal" are
"HIV Infections" (2 trials), "Mycobacterium Avium-intracellulare Infection" (1 trials) and "Toxoplasmosis, Cerebral" (1 trials). Many other conditions were trialed in "Dr Emil Toma / Hotel Dieu de Montreal" in a lesser frequency.
Clinical Trials Intervention Types at Dr Emil Toma / Hotel Dieu de Montreal
Most popular intervention types in "Dr Emil Toma / Hotel Dieu de Montreal" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atovaquone" (1 trials) and "Rifabutin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Dr Emil Toma / Hotel Dieu de Montreal
The vast majority of trials in "Dr Emil Toma / Hotel Dieu de Montreal" are
2 trials for "All" genders.
Clinical Trials Status at Dr Emil Toma / Hotel Dieu de Montreal
Currently, there are NaN active trials in "Dr Emil Toma / Hotel Dieu de Montreal".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Dr Emil Toma / Hotel Dieu de Montreal,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Dr Emil Toma / Hotel Dieu de Montreal, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".